Replies to post #75690 on Cannabis Science Inc (fka CBIS)

[sta loose]

Included in the release issued on, 7/23/12
Cannabis Science is currently working with CBR International to develop a Pre-IND Application to the FDA that focuses on the use of CS-S/BCC-1 topical cannabis-based preparations for the treatment of basal and squamous cell carcinomas